It was reported that restenosis occurred.On (b)(6) 2016, the patent was enrolled in the imperial study and the index procedure was performed the same day.The target lesion was located in the right leg mid superficial femoral artery (sfa) with 100% stenosis and was 125mm long with a proximal reference vessel diameter of 4mm and distal vessel diameter of 4mm and was classified as tasc ii d lesion.The lesion was treated with pre-dilatation and placement of a 6.0 x 150mm study stent.Following post dilatation, residual stenosis was 0%.On (b)(6) 2018, during the 24 month follow up, dus was performed and revealed 50-99% in-stent restenosis of the previously placed study stent in the proximal portion of the right sfa - neointimal hyperplasia.On (b)(6) 2018, the patient was hospitalized for further evaluation and treatment.On the same day, 80% in-stent restenosis of the previously placed study stent in the proximal portion of the right sfa was treated with laser athrectomy and placement of a 6 x 40mm zilver stent.Post dilatation, there was no evidence of embolization or dissection.The patient was discharged on the same day on dapt.
|